Aldehyde dehydrogenase 2 rs671 a/A Genotype is Associated with an Increased Risk of Early Onset Coronary Artery Stenosis

References

• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–533. doi:10.1038/s41586-021-03392-8
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Agabiti-Rosei C, De Ciuceis C, Boari GEM. Subclinical hypertension-mediated organ damage (HMOD) in hypertension: atherosclerotic cardiovascular disease (ASCVD) and calcium score. High Blood Press Cardiovasc Prev. 2023;30(1):17–27. doi:10.1007/s40292-022-00551-4
   PubMed Web of Science ®Google Scholar
• Sheikh Beig Goharrizi MA, Ghodsi S, Memarjafari MR. Implications of CRISPR-Cas9 genome editing methods in atherosclerotic cardiovascular diseases. Curr Probl Cardiol. 2023;48(5):101603. doi:10.1016/j.cpcardiol.2023.101603
   PubMed Web of Science ®Google Scholar
• Mézquita AJV, Biavati F, Falk V. Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a consensus statement from the quantitative cardiovascular imaging study group. Nat Rev Cardiol. 2023;20(10):696–714. doi:10.1038/s41569-023-00880-4
   PubMed Web of Science ®Google Scholar
• Min JK, Chandrashekhar Y. Atherosclerosis, stenosis, and ischemia: one primary, one secondary, and one tertiary. JACC Cardiovasc Imaging. 2018;11(4):531–533. doi:10.1016/j.jcmg.2017.12.006
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421. PMID: 12485966. doi:10.1161/circ.106.25.3143
   PubMed Web of Science ®Google Scholar
• Duan Y, Gao Y, Zhang J, et al. Mitochondrial aldehyde dehydrogenase 2 protects gastric mucosa cells against DNA damage caused by oxidative stress. Free Radic Biol Med. 2016;93:165–176. doi:10.1016/j.freeradbiomed.2016.02.001
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu Y, Hua S, Zhou S, Wang K. ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress. Int J Clin Exp Med. 2015;8(5):6794–6803. PMID: 26221217.
   PubMed Web of Science ®Google Scholar
• Lin CL, Chien RN, Chen LW. The aldehyde dehydrogenase ALDH2*2 allele, associated with alcohol drinking behavior, dates back to prehistoric times. Biomolecules. 2021;11(9):1376. doi:10.3390/biom11091376
   PubMed Web of Science ®Google Scholar
• Wang W, Wang C, Xu H, Aldehyde Dehydrogenase GY. Liver Disease and Cancer. Int J Biol Sci. 2020;16(6):921–934. doi:10.7150/ijbs.42300
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo Y, Zhao X. The role of aldehyde dehydrogenase 2 in cardiovascular disease. Nat Rev Cardiol. 2023;20(7):495–509. doi:10.1038/s41569-023-00839-5
   PubMed Web of Science ®Google Scholar
• Maiuolo J, Oppedisano F, Carresi C. The generation of nitric oxide from aldehyde dehydrogenase-2: the role of dietary nitrates and their implication in cardiovascular disease management. Int J Mol Sci. 2022;23(24):15454. doi:10.3390/ijms232415454
   PubMed Web of Science ®Google Scholar
• Yoshida A, Rzhetsky A, Hsu LC, Chang C. Human aldehyde dehydrogenase gene family. Eur J Biochem. 1998;251(3):549–557. doi:10.1046/j.1432-1327.1998.2510549.x
   PubMedGoogle Scholar
• Mizoi Y, Yamamoto K, Ueno Y, Fukunaga T, Harada S. Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol. 1994;29(6):707–710. PMID: 7695788.
   PubMed Web of Science ®Google Scholar
• Perez-Miller S, Younus H, Vanam R, Chen CH, Mochly-Rosen D, Hurley TD. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol. 2010;17(2):159–164. doi:10.1038/nsmb.1737
   PubMed Web of Science ®Google Scholar
• Chen YC, Peng GS, Tsao TP, Wang MF, Lu RB, Yin SJ. Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet Genomics. 2009;19(8):588–599. doi:10.1097/FPC.0b013e32832ecf2e
   PubMed Web of Science ®Google Scholar
• Qu Y, Zhang HL, Yu LM, Sun Y, Wu HL, Chen YG. Aldehyde dehydrogenase 2 polymorphism as a protective factor for intracranial vascular stenosis in ischemic stroke in Han Chinese. Int J Neurosci. 2016;126(4):342–347. doi:10.3109/00207454.2015.1017760
   PubMed Web of Science ®Google Scholar
• Sung YF, Lu CC, Lee JT, et al. Homozygous ALDH2*2 is an independent risk factor for ischemic stroke in Taiwanese men. Stroke. 2016;47(9):2174–2179. doi:10.1161/STROKEAHA.116.013204
   PubMed Web of Science ®Google Scholar
• He W, Li Q, Yang M, et al. Lower BMI cutoffs to define overweight and obesity in China. Obesity. 2015;23(3):684–691. doi:10.1002/oby.20995
   PubMed Web of Science ®Google Scholar
• Tang J, Zhu X, Chen Y, et al. Association of maternal pre-pregnancy low or increased body mass index with adverse pregnancy outcomes. Sci Rep. 2021;11(1):3831. doi:10.1038/s41598-021-82064-z
   PubMed Web of Science ®Google Scholar
• Kishi S, Magalhães TA, Cerci RJ, et al. Comparative effectiveness of coronary artery stenosis and atherosclerotic plaque burden assessment for predicting 30-day revascularization and 2-year major adverse cardiac events. Int J Cardiovasc Imaging. 2020;36(12):2365–2375. doi:10.1007/s10554-020-01851-3
   PubMed Web of Science ®Google Scholar
• Kim S, Kang W, Cho S, et al. Associations between blood lead levels and coronary artery stenosis measured using coronary computed tomography angiography. Environ Health Perspect. 2021;129(2):27006. doi:10.1289/EHP7351
   PubMed Web of Science ®Google Scholar
• Zhong S, Li L, Liang N, et al. Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver. Redox Biol. 2021;41:101919. doi:10.1016/j.redox.2021.101919
   PubMed Web of Science ®Google Scholar
• Luo J, Lu Z, Zhong Z, et al. ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolism. Free Radic Biol Med. 2023;212:34–48. doi:10.1016/j.freeradbiomed.2023.12.017
   PubMed Web of Science ®Google Scholar
• Xu L, Zhao G, Wang J, et al. Impact of genetic variation in aldehyde dehydrogenase 2 and alcohol consumption on coronary artery lesions in Chinese patients with stable coronary artery disease. Int Heart J. 2018;59(4):689–694. doi:10.1536/ihj.17-165
   PubMed Web of Science ®Google Scholar
• Zhang LL, Wang YQ, Fu B, Zhao SL, Kui Y. Aldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysis. Genet Mol Res. 2015;14(4):18503–18514. doi:10.4238/2015.December.23.38
   PubMed Web of Science ®Google Scholar
• Ye CY, Xin JR, Li Z, et al. ALDH2, ADCY3 and BCMO1 polymorphisms and lifestyle-induced traits are jointly associated with CAD risk in Chinese Han people. Gene. 2022;807:145948. doi:10.1016/j.gene.2021.145948
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Hokimoto S, Harada E, Kinoshita K, Yoshimura M, Yasue H. Variant aldehyde dehydrogenase 2 (ALDH2*2) in east asians interactively exacerbates tobacco smoking risk for coronary spasm- possible role of reactive aldehydes. Circ J. 2016;81(1):96–102. doi:10.1253/circj.CJ-16-0969
   PubMed Web of Science ®Google Scholar
• Wei S, Zhang L, Bailu W, et al. ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression. Biochem Biophys Res Commun. 2019;512(1):41–48. doi:10.1016/j.bbrc.2019.02.012
   PubMed Web of Science ®Google Scholar
• Roy B, Sundar K, Palaniyandi SS. 4-hydroxy-2-nonenal decreases coronary endothelial cell migration: potentiation by aldehyde dehydrogenase 2 inhibition. Vascul Pharmacol. 2020;131:106762. doi:10.1016/j.vph.2020.106762
   PubMed Web of Science ®Google Scholar
• Yang MY, Wang YB, Han B, et al. Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells. Acta Pharmacol Sin. 2018;39(1):48–58. doi:10.1038/aps.2017.81
   PubMed Web of Science ®Google Scholar
• Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2021;143(21):e984–e1010. doi:10.1161/CIR.0000000000000973
   PubMed Web of Science ®Google Scholar
• Dikaiou P, Björck L, Adiels M, et al. Obesity, overweight and risk for cardiovascular disease and mortality in young women. Eur J Prev Cardiol. 2021;28(12):1351–1359. doi:10.1177/2047487320908983
   PubMed Web of Science ®Google Scholar
• Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J. 2020;41(2):221–226. doi:10.1093/eurheartj/ehz388
   PubMed Web of Science ®Google Scholar
• Abdul-Rahman T, Lizano-Jubert I, Garg N, et al. The common pathobiology between coronary artery disease and calcific aortic stenosis: evidence and clinical implications. Prog Cardiovasc Dis. 2023;79:89–99. doi:10.1016/j.pcad.2023.06.002
   PubMed Web of Science ®Google Scholar
• Lind L, Markstad H, Ahlström H, et al. Obesity is associated with coronary artery stenosis independently of metabolic risk factors: the population-based SCAPIS study. Atherosclerosis. 2022;362:1–10. doi:10.1016/j.atherosclerosis.2022.10.007
   PubMed Web of Science ®Google Scholar
• Lowenstern A, Ng N, Takagi H. Influence of obesity on coronary artery disease and clinical outcomes in the ADVANCE registry. Circ Cardiovasc Imaging. 2023;16(5):e014850. doi:10.1161/CIRCIMAGING.122.014850
   PubMed Web of Science ®Google Scholar
• Nafakhi H, Al-Mosawi AA, Al-Buthabhak K. Sex-related differences in the association of BMI and pericardial fat volume with coronary atherosclerotic markers in young. Angiology. 2021;72(3):285–289. doi:10.1177/0003319720974237
   PubMed Web of Science ®Google Scholar
• Auer J, Weber T, Berent R, et al. Obesity, body fat and coronary atherosclerosis. Int J Cardiol. 2005;98(2):227–235. doi:10.1016/j.ijcard.2003.11.007
   PubMed Web of Science ®Google Scholar
• Carbone S, Canada JM, Billingsley HE, Siddiqui MS, Elagizi A, Lavie CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100. doi:10.2147/VHRM.S168946
   PubMed Web of Science ®Google Scholar
• Jang JJ, Bhapkar M, Coles A, et al. Predictive model for high-risk coronary artery disease. Circ Cardiovasc Imaging. 2019;12(2):e007940. doi:10.1161/CIRCIMAGING.118.007940
   PubMed Web of Science ®Google Scholar
• Kuneman JH, El Mahdiui M, van Rosendael AR, et al. Coronary volume to left ventricular mass ratio in patients with diabetes mellitus. J Cardiovasc Comput Tomogr. 2022;16(4):319–326. doi:10.1016/j.jcct.2022.01.004
   PubMed Web of Science ®Google Scholar
• Iribarren C, Go AS, Husson G, et al. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol. 2006;48(9):1800–1807. doi:10.1016/j.jacc.2006.03.070
   PubMed Web of Science ®Google Scholar
• Larsson SC, Mason AM, Bäck M, et al. Genetic predisposition to smoking in relation to 14 cardiovascular diseases. Eur Heart J. 2020;41(35):3304–3310. doi:10.1093/eurheartj/ehaa193
   PubMed Web of Science ®Google Scholar
• Sun J, Han W, Wu S, et al. Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study. BMC Cardiovasc Disord. 2021;21(1):484. doi:10.1186/s12872-021-02302-0
   PubMed Web of Science ®Google Scholar
• Nardin M, Verdoia M, Negro F, Rolla R, Tonon F, De Luca G. Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease. Eur J Clin Invest. 2020;50(2):e13181. doi:10.1111/eci.13181
   PubMed Web of Science ®Google Scholar
• Imatoh T, Miyazaki M, Kadowaki K, Babazono A, Sato M, Une H. Interaction of low serum adiponectin levels and smoking on coronary stenosis in Japanese men. Int J Cardiol. 2006;110(2):251–255. doi:10.1016/j.ijcard.2005.11.039
   PubMed Web of Science ®Google Scholar
• Majumder AR, Rahman MA, Momen A, et al. Association of Echocardiographic Epicardial Fat Thickness with the Angiographic Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome. Mymensingh Med J. 2022;31(1):142–148. PMID: 34999694.
   PubMedGoogle Scholar
• Bolorunduro O, Cushman C, Kapoor D, et al. Comparison of coronary atherosclerotic plaque burden and composition of culprit lesions between cigarette smokers and non-smokers by in vivo virtual histology intravascular ultrasound. J Invasive Cardiol. 2015;27(8):354–358. PMID: 25999135.
   PubMed Web of Science ®Google Scholar